摘要:
A multipurpose shower head fixing device and a shower fixing device are provided, wherein the shower head fixing device comprises a connecting and fixing piece having a wrench structure and a shower head connecting mechanism, and the shower fixing device comprises a switching valve and the shower head fixing device. According to the invention, the structure with a wrench function is additionally provided on the connecting and fixing piece, thus, when the multipurpose shower head fixing device works with the switching valve cooperatively, no wrench is needed additionally, and a locking nut of the switching valve can be locked when the locking nut is matched with the wrench structure of the connecting and fixing piece.
摘要:
The present invention relates to ADAMTS-1 and uses thereof. The present invention also relates to fragments of ADAMTS-1 and methods of inhibiting cell growth and metastasis. The present invention also provide methods of identifying inhibitors and activators relating to the function of ADAMTS-1.
摘要:
Pharmaceutical compositions and methods for treating cancer using CD44 antagonists are disclosed. In certain aspects, these pharmaceutical compositions and methods include treating a mammal having a cancer, such as glioma, colon cancer, breast cancer, prostate cancer, ovarian cancer, lung cancer, renal cell carcinoma, gastric cancer, esophageal cancer, head cancer, neck cancer, pancreatic cancer, or melanoma, with a CD44 fusion protein. These CD44 fusion proteins include CD44-Fc fusions and can be used to detect hyaluronan.
摘要:
The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.
摘要:
The present invention relates to ADAMTS-1 and uses thereof. The present invention also relates to fragments of ADAMTS-1 and methods of inhibiting cell growth and metastasis. The present invention also provide methods of identifying inhibitors and activators relating to the function of ADAMTS-1.
摘要:
Dynamic return type generation in a database system. A request is received to execute a first function. A second function is executed if the first function is defined to return data in a first type of data structure. When executed, the second function returns formatting information that indicates an arrangement of fields of data within the first type of data structure. The first function is executed to obtain a collection of data formatted according to the first type of data structure, and the collection of data is organized according to the formatting information returned by the second function.
摘要:
Dynamic return type generation in a database system. A request is received to execute a first function. A second function is executed if the first function is defined to return data in a first type of data structure. When executed, the second function returns formatting information that indicates an arrangement of fields of data within the first type of data structure. The first function is executed to obtain a collection of data formatted according to the first type of data structure, and the collection of data is organized according to the formatting information returned by the second function.
摘要:
The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.
摘要:
Pharmaceutical compositions that comprise a pharmaceutically acceptable carrier and either a therapeutically effective amount of an ECM-binding fragment of Ang-1 protein that comprises SEQ ID NO:1 and/or SEQ ID NO:2 or a homologous peptide thereof and pharmaceutical compositions that comprise a pharmaceutically acceptable carrier and a vector comprising a nucleic acid molecule that comprises the nucleotide sequence that encodes an ECM-binding fragment of Ang-1 protein that comprises SEQ ID NO:1 and/or SEQ ID NO:2 or a homologous peptide thereof are disclosed. Methods of using such compositions to treat individuals suspected of having coronary artery disease, vascular disease or a condition involving ischemia and to promote angiogenesis, endothelial survival and maintaining vascular integrity are disclosed. Methods to identify compounds that modulates binding of Ang-1 to ECM are disclosed. Pharmaceutical compositions which comprise a therapeutically effective amount of Ang-2 protein and/or a vector comprising a nucleic acid molecule that comprises the nucleotide coding sequence of Ang-2 and methods of using such compositions to treat individuals suspected of having cancer are disclosed.
摘要翻译:包含药学上可接受的载体和治疗有效量的包含SEQ ID NO:1和/或SEQ ID NO:2的Ang-1蛋白的ECM结合片段或其同源肽的药物组合物和包含 药学上可接受的载体和载体,其包含核酸分子,其包含编码包含SEQ ID NO:1和/或SEQ ID NO:2或其同源肽的Ang-1蛋白的ECM结合片段的核苷酸序列 披露 公开了使用这些组合物治疗怀疑有冠状动脉疾病,血管疾病或涉及缺血的病症并促进血管发生,内皮存活和维持血管完整性的方法。 公开了鉴定调节Ang-1与ECM结合的化合物的方法。 公开了包含治疗有效量的Ang-2蛋白和/或包含含有Ang-2的核苷酸编码序列的核酸分子的载体的药物组合物和使用该组合物治疗疑似患有癌症的个体的方法。
摘要:
Techniques for partitioning nested tables are provided. A parent table includes a column for collection items. A nested table is created for storing items that belong to the collection items. The nested table is partitioned to create a plurality of nested table partitions. Each nested table partition is a distinct, separately stored structure within a database. How the nested table is partitioned may, or may not, be based on how the parent table is partitioned. For example, a nested table may be partitioned based on the same criteria in which the parent table is partitioned. As another example, a nested table may be partitioned, whereas the parent table is not partitioned.